ARCTURUS THERAPEUTICS HOLDINGS INC. Contractual Obligation
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Contractual Obligation of $3.49 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Commitment and Contingencies
us-gaap:ContractualObligation · last filed 2023-11-14
- 2023-09-30: Contractual Obligation $3.49M.
- 2022-12-31: Contractual Obligation $7.47M.
| Period end | Contractual Obligation |
|---|---|
| 2023-09-30 | $3.49M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $7.47M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |